Synthesis of trans-3'-substituted-CCG-IV analogs and their characterization to ionotropic glutamate receptors

Bioorganic and Medicinal Chemistry Letters

Volumn 6, Issue 20, 1996, Pages 2381-2386

  Shimamoto, Keiko ^a   Shigeri, Yasushi ^b   Nakajima, Terumi ^a   Yumoto, Noboru ^b   Yoshikawa, Susumu ^b   Ohfune, Yasufumi ^c  

^a SUNTORY INSTITUTE FOR BIOORGANIC RESEARCH   (Japan)

^b OSAKA NATIONAL RESEARCH INSTITUTE   (Japan)

^c Osaka Prefecture University   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2,3 DICARBOXYCYCLOPROPYL)GLYCINE; 2 AMINO 5 PHOSPHONOVALERIC ACID; 4 PHOSPHONOMETHYLPIPECOLIC ACID; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; GLUTAMATE RECEPTOR; GLUTAMIC ACID; GLYCINE DERIVATIVE; KAINIC ACID;

ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; ELECTROPHYSIOLOGY; MOTONEURON; NONHUMAN; RAT; SPINAL CORD; STEREOCHEMISTRY;

ANIMALIA;

EID: 0030598193     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-894X(96)00436-2     Document Type: Article

References (29)

1. 1. (a) Shimamoto, K.; Ishida, M.; Shinozaki, H.; Ohfune, Y. J. Org. Chem. 1991, 56, 4167.
2. (b) Yamanoi, K.; Ohfune, Y.; Watanabe, K.; Li, P. -N.; Takeuchi, H. Tetrahedron Lett. 1988, 29, 1181.
3. 2. Ohfune, Y.; Shimamoto, K.; Ishida, M.; Shinozaki, H. Bioorg. Med. Chem. Lett. 1993, 3, 15.
4. 3. Shimamoto, K.; Ohfune, Y. J. Med. Chem. 1996, 39, 407 and references cited therein.
5. 4. Ishida, M.; Ohfune, Y.; Shimada, Y.; Shimamoto, K.; Shinozaki, H. Brain Res. 1991, 550, 152.
6. 5. Shimamoto, K.; Ohfune, Y. Tetrahedron Lett. 1990, 31, 4049.
7. 6. Padwa, A.; Austin, D. J. Angew. Chem. Int. Ed. Eng. 1994, 33, 1797.
8. 7. (a) Doyle, M. P.; Austin, R. E.; Bailey, A. S.; Dwyer, M. P.; Dyatkin, A. B.; Kalinin, A. V.; Kwan, M. M. Y.; Liras, S.; Oalmann, C. J.; Pierters, R. J.; Protopopova, M. N.; Raab, C. E.; Roos, G. H. S.; Zhou, Q.-L.; Martin, S. F. J. Am. Chem. Soc. 1995, 117, 5763.
9. (b) Martin, S. F.; Spaller, M. R.; Liras, S.; Hartmann, B. J. Am. Chem. Soc. 1994, 116, 4493.
10. (c) Doyle, M. P.; Winchester, W. R.; Hoorn, J. A. A.; Lynch, V.; Simonsen, S. H.; Ghosh, R. J. Am. Chem. Soc. 1993, 115, 9968.
11. (d) Doyle, M. P.; Dyatkin, A. B.; Kalinin, A. V.; Ruppar, D. A.; Martin, S. F.; Spaller, M. R.; Liras, S. J. Am. Chem. Soc. 1995, 117, 11021.
12. 8. Raghavan, S.; Ishida, M.; Shinozaki, H.; Nakanishi, K.; Ohfune, Y. Tetrahedron Lett. 1993, 34, 5765.
13. 9. Tebbe, F. N.; Parshall, G. W.; Reddy, G. S. J. Am. Chem. Soc. 1978, 100, 3611.
14. 10. Electrophysiological studies were performed on a modified version of the neonatal rat hemisected spinal cord preparation (Otsuka, M.; Konishi, S. Nature, 1974, 252, 733.) using tissue from 2-7 days old Wistar rats. Relative potency values (RP) were calculated as follows from kainate dose-response curve (0.1-10 μM) determined in each experiment. RP(%) = (Concentration of KA to produce the same effect X) / (Concentration of the test compound to produce an effect X) × 100. Each RP value was the mean of values from at least 3 different concentrations (1-10 μM) of the test compound.
15. 11. Depression ratio was represented as average percentage decrease in hight of depolarization compared to pre-or post-antagonist control.
16. 12. Isolated dorsal root C-fibers were found to possess KA-sensitive receptors and respond strongly to KA but only weakly to AMPA. (a) Pook, P.; Brugger, F.; Hawkins, N. S.; Clark, K. C.; Watkins, J. C.; Evans, R. H. Br. J. Pharmacol. 1993, 108, 179.
17. (b) Ishida, M.; Shinozaki, H. Br. J. Pharmacol. 1991, 104, 873.
18. (c) Agrawal, S. G.; Evans, R. H. Br. J. Pharmacol. 1986, 87, 345.
19. 13. Studies were performed on a modified version (Evans, R. H.; Evans, S. J.; Pook, P. C.; Sunter, D. C. Br. J. Pharmacol. 1987, 91, 531) of the neonatal (1-3 days) rat dorsal root preparation.
20. 14. (a) London, E. D.; Coyle, J. T. Mol Pharmacol. 1979, 15, 492.
21. (b) Murphy, D. E.; Snowhill, E. W.; Williams, M. Neurochem. Res. 1987, 12, 775.
22. (c) Murphy, D. E.; Hutchison, A. J.; Hurt, S. D.; Williams, M.; Sills, M. A. Br. J. Pharmacol. 1988, 95, 932.
23. (d) Kawai, M.; Horikawa, Y.; Ishihara, T.; Shimamoto, K.; Ohfune, Y. Eur. J. Pharmacol. 1992, 211, 195.
24. 15. (a) Kwak, S.; Aizawa, H.; Ishida, M.; Shinozaki, H. Neurosci. Lett. 1992, 139, 206.
25. (b) Shinozaki et al. reported a simitar observation on the binding of CPG-IV; Saitoh, T.; Ishida, M.; Shinozaki, H. The 116th Annual Meeting of the Pharmaceutical Society of Japan (1996), J1-13-4.
26. 16. In our preliminary results, substituted willardiines which caused significant depolarization on C-fiber had also weak affinity for binding to KA receptors in the rat brain membranes. (a) Wong, L. A.; Mayer, M. L.; Jane, D. E.; Watkins, J. C. J. Neurosci. 1994, 14, 3881.
27. (b) Patneau, D. K.; Mayer, M. L.; Jane, D. E.; Watkins, J. C. J. Neurosci. 1992, 12, 595.
28. 17. (a) Selvin, J. T.; Collins, J. F.; Coyle, J. T. Brain Res. 1983, 265, 169.
29. (b) Conway, G. A.; Park, J. S.; Maggiora, L.; Mertes, M.P.; Galton, N. J. Med. Chem. 1984, 27, 52.